Abstract | PURPOSE: METHODS: A 14-month-old male infant developed a peripapillary choroidal neovascular membrane 10 months after lens-sparing vitrectomy that he underwent for persistent fetal vasculature syndrome and confirmed on angiography and optical coherence tomography. A single dose of intravitreal pegaptanib sodium (0.3 mg) was administered after informed consent was obtained. Angiography and optical coherence tomography scans were performed at 6 and 14 weeks after the injection to determine the result. RESULTS: Six weeks after the single injection, the lesion reduced in size and exhibited less leakage on angiography. At 14 weeks, leakage was absent, and the lesion had involuted. CONCLUSION:
|
Authors | Anand Vinekar, Newman Sund, Polly Quiram, Antonio Capone Jr |
Journal | Retina (Philadelphia, Pa.)
(Retina)
Vol. 30
Issue 4 Suppl
Pg. S41-4
(Apr 2010)
ISSN: 1539-2864 [Electronic] United States |
PMID | 20419850
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Aptamers, Nucleotide
- Vascular Endothelial Growth Factor A
- pegaptanib
|
Topics |
- Aptamers, Nucleotide
(therapeutic use)
- Choroidal Neovascularization
(diagnosis, drug therapy, etiology, physiopathology)
- Fluorescein Angiography
- Humans
- Infant
- Injections
- Male
- Persistent Hyperplastic Primary Vitreous
(surgery)
- Postoperative Complications
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
- Visual Acuity
(physiology)
- Vitrectomy
- Vitreous Body
|